{
    "root": "80aea4ac-ada6-445f-ad96-8cc300e4a499",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Isotretinoin",
    "value": "20250516",
    "ingredients": [
        {
            "name": "ISOTRETINOIN",
            "code": "EH28UP18IF",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6067"
        },
        {
            "name": "SORBITAN MONOOLEATE",
            "code": "06XEA2VD56",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_183688"
        },
        {
            "name": "SOYBEAN OIL",
            "code": "241ATL177A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_166975"
        },
        {
            "name": "PEG-32 HYDROGENATED PALM GLYCERIDES",
            "code": "G6EP177239"
        },
        {
            "name": ".ALPHA.-TOCOPHEROL",
            "code": "H4N855PNZ1"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C GREEN NO. 3",
            "code": "3P3ONR6O1S"
        },
        {
            "name": "D&C YELLOW NO. 10 ALUMINUM LAKE",
            "code": "CQ3XH3DET6"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FD&C BLUE NO. 2--ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        }
    ],
    "indications": {
        "text": "isotretinoin capsules indicated treatment severe recalcitrant nodular acne non-pregnant patients 12 years age older multiple inflammatory nodules diameter 5 mm greater . significant associated , isotretinoin capsules reserved patients severe nodular acne unresponsive conventional therapy , including systemic antibiotics . limitations : second course isotretinoin capsules therapy needed , recommended two-month waiting period patient \u2019 acne may continue improve following 15 20-week course therapy [ ( 2.2 ) ] .",
        "doid_entities": [
            {
                "text": "acne (DOID:6543)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6543"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "severe nodular acne",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_169802"
            }
        ]
    },
    "contraindications": {
        "text": "isotretinoin capsules substitutable absorica ld \u00ae different bioavailability recommended . ( 2.1 , 5.3 ) recommended isotretinoin capsules 0.5 1 mg/kg/day given two divided doses without regard meals 15 20 weeks ( 2.1 ) adult patients severe disease ( scarring , trunk involvement ) may increase 2 mg/kg/day isotretinoin capsules divided doses . ( 2.1 ) daily dosing recommended . ( 2.1 ) dose isotretinoin capsules missed , skip dose . take two doses isotretinoin capsules time . ( 2.1 ) perform pregnancy tests prior prescribing , month therapy , end therapy , one month discontinuation . ( 2.3 , 8.3 ) prior prescribing , perform fasting lipid profile liver function tests . ( 2.3 )",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "isotretinoin capsules , usp supplied follows : 10 mg capsules : white opaque/white opaque size 1 capsules imprinted wpi 2433 black ink filled yellow semi-solid banded blue band.box 30 capsules ( 3 x 10 prescription packs ) : ndc 0591-2433-15 20 mg capsules : white opaque/light yellow opaque size 0 capsules imprinted wpi 2434 black ink filled yellow semi-solid banded blue band.box 30 capsules ( 3 x 10 prescription packs ) : ndc 0591-2434-15 25 mg capsules : light green opaque/light green opaque size 0 capsules imprinted wpi a128 black ink filled yellow semi-solid banded blue band.box 30 capsules ( 3 x 10 prescription packs ) : ndc 0591-2451-15 30 mg capsules : orange opaque/orange opaque size 00 capsules imprinted wpi 2435 black ink filled yellow semi-solid banded blue band.box 30 capsules ( 3 x 10 prescription packs ) : ndc 0591-2435-15 35 mg capsules : flesh opaque/flesh opaque size 00 capsules imprinted wpi a168 black ink filled yellow semi-solid banded blue band.box 30 capsules ( 3 x 10 prescription packs ) : ndc 0591-2501-15 40 mg capsules : orange opaque/orange opaque size 00 capsules imprinted wpi 2436 black ink filled yellow semi-solid banded blue band.box 30 capsules ( 3 x 10 prescription packs ) : ndc 0591-2436-15 storage handling isotretinoin capsules , usp store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . protect light .",
    "adverseReactions": "pregnancy ( 4.1 , 8.1 ) hypersensitivity product components ( 4.2 , 5.14 )",
    "indications_original": "Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, isotretinoin capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.\n                  \n                     Limitations of Use:\n                  If a second course of isotretinoin capsules therapy is needed, it is not recommended before a two-month waiting period because the patient\u2019s acne may continue to improve following a 15 to 20-week course of therapy [see Dosage and Administration (2.2)].",
    "contraindications_original": "Isotretinoin capsules are not substitutable with ABSORICA LD \u00ae because of different bioavailability and recommended dosage. ( 2.1 , 5.3 ) Recommended dosage for isotretinoin capsules is 0.5 to 1 mg/kg/day given in two divided doses without regard to meals for 15 to 20 weeks ( 2.1 ) Adult patients with very severe disease (scarring, trunk involvement) may increase dosage to 2 mg/kg/day of isotretinoin capsules in divided doses. ( 2.1 ) Once daily dosing is not recommended. ( 2.1 ) If a dose of isotretinoin capsules is missed, just skip that dose. Do not take two doses of isotretinoin capsules at the same time. ( 2.1 ) Perform pregnancy tests prior to prescribing, each month during therapy, end of therapy, and one month after discontinuation. ( 2.3 , 8.3 ) Prior to prescribing, perform fasting lipid profile and liver function tests. ( 2.3 )",
    "warningsAndPrecautions_original": "Isotretinoin capsules, USP are supplied as follows:\n                  \n                     \n                        10 mg capsules: White opaque/white opaque size 1 capsules imprinted with WPI and 2433 in black ink and filled with a yellow semi-solid and banded with a blue band.Box of 30 capsules (3 x 10 Prescription Packs): NDC 0591-2433-15\n                     \n                        20 mg capsules:\u00a0White opaque/light yellow opaque size 0 capsules imprinted with WPI and 2434 in black ink and filled with a yellow semi-solid and banded with a blue band.Box of 30 capsules (3 x 10 Prescription Packs): NDC 0591-2434-15\n                     \n                        25 mg capsules: Light green opaque/light green opaque size 0 capsules imprinted with WPI and A128 in black ink and filled with a yellow semi-solid and banded with a blue band.Box of 30 capsules (3 x 10 Prescription Packs): NDC 0591-2451-15\n                     \n                        30 mg capsules: Orange opaque/orange opaque size 00 capsules imprinted with WPI and 2435 in black ink and filled with a yellow semi-solid and banded with a blue band.Box of 30 capsules (3 x 10 Prescription Packs): NDC 0591-2435-15\n                     \n                        35 mg capsules: Flesh opaque/flesh opaque size 00 capsules imprinted with WPI and A168 in black ink and filled with a yellow semi-solid and banded with a blue band.Box of 30 capsules (3 x 10 Prescription Packs): NDC 0591-2501-15\n                     \n                        40 mg capsules: Orange opaque/orange opaque size 00 capsules imprinted with WPI and 2436 in black ink and filled with a yellow semi-solid and banded with a blue band.Box of 30 capsules (3 x 10 Prescription Packs): NDC 0591-2436-15\n                  \n                  \n                     Storage and Handling of Isotretinoin Capsules, USP\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. Protect from light.",
    "adverseReactions_original": "Pregnancy ( 4.1 , 8.1 ) Hypersensitivity to this product or any of its components ( 4.2 , 5.14 )",
    "drug": [
        {
            "name": "Isotretinoin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6067"
        }
    ]
}